In plain English
The Executive Office of Health and Human Services wants to fund providers who can offer speech-language pathology services. This includes evaluating, trialing, and distributing tablets as communication devices for MassHealth members. Applications are due by March 15, 2024.
About this bid
EOHHS is issuing this RFA to solicit applications from eligible MassHealth-enrolled Providers of Outpatient Speech-Language pathology services. The purpose of this RFA is to facilitate an initiative to provide the evaluation, data driven trial, and distribution of Tablets to be used as Augmentative and Alternative Communication (AAC) devices to serve as Speech Generating Devices (SGD). The SGD devices will be configured to meet the functional speaking needs of qualified MassHealth Members. Point of contact: Kerisotellia Akins ([email protected]). Solicitation BD-25-1039-EHS01-ASHWA-112848 from Executive Office of Health and Human Services. Full documents and how to quote are on COMMBUYS,…
Details
- Agency
- EHS01 - EHS
- Classification (PSC)
- Politics and Civic Affairs Services (UNSPSC 93-14-00)
- Place of performance
- Boston, Massachusetts
How to access this bid
Click “View the original posting” — it opens the full bid on COMMBUYS (no account needed).
Documents download straight from the bid page — also no account.
To quote electronically, register a free COMMBUYS vendor account; otherwise follow the submission directions in the bid.
Documents
Listed on the original posting. Download them from the agency's portal.
- RFA AAC Tablet Initiative
- Attachment A-Model Special Conditions Addendum
- Attachment B AAC Tablet Initiative Location details
- Attachment C Provider Response for Participation AAC Tablet RFA
- Evaluation Criteria for RFA AAC Tablet Initiative
- AAC Tablet Initiative RFA - Amendment 1
- RFA AAC Tablet Initiative Applicant Conference Slides
- Q and A - RFA AAC Tablets
New to this kind of bid?
Read the plain-English guide: what the agency wants, the key dates, and how to put together a competitive response.
